Ambulatory blood pressure is associated with measured glomerular filtration rate in the general middle-aged population

Journal of Hypertension

Volumn 30, Issue 3, 2012, Pages 497-504

  Mathisen, Ulla D ^a,c   Melsom, Toralf ^a,c   Ingebretsen, Ole C ^b,c   Jenssen, Trond G ^c,d,e   Njølstad, Inger ^c   Solbu, Marit D ^a   Toft, Ingrid ^a,c   Eriksen, Bjørn O ^a,c  

^a Division of Internal Medicine   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c Department of Clinical Medicine ^*  (Norway)

^d UNIVERSITY OF TROMSØ   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

ambulatory blood pressure; epidemiology; glomerular filtration rate

Indexed keywords

ADULT; AMBULATORY BLOOD PRESSURE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CONFERENCE PAPER; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY CLEARANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POPULATION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 84857063902     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834f973a     Document Type: Conference Paper

References (44)

1. Hsu Cy, McCulloch CE, Darbinian J, Go AS, Iribarren C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 2005; 165:923-928. (Pubitemid 40563240)
2. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334:13-18. (Pubitemid 26012498)
3. Tozawa M, Iseki K, Iseki C, Kinjo K, Ikemiya Y, Takishita S. Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension 2003; 41:1341-1345. (Pubitemid 36706087)
4. Johnson RJ, Feig DI, Nakagawa T, Sanchez-Lozada LG, Rodriguez-Iturbe B. Pathogenesis of essential hypertension: historical paradigms and modern insights. J Hypertens 2008; 26:381-391. (Pubitemid 351317242)
5. Nitsch D, Dietrich DF, von Eckardstein A, Gaspoz JM, Downs SH, Leuenberger P, et al. Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study. Nephrol Dial Transplant 2006; 21:935-944.
6. Verhave JC, Hillege HL, Burgerhof JGM, Gansevoort RT, de Zeeuw D, Jong PED. The association between atherosclerotic risk factors and renal function in the general population. Kidney Int 2005; 67:1967-1973. (Pubitemid 40577733)
7. Foley RN, Wang C, Collins AJ. Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III study. Mayo Clin Proc 2005; 80:1270-1277. (Pubitemid 41395958)
8. Di Angelantonio E, Chowdhury R, Sarwar N, Aspelund T, Danesh J, Gudnason V. Chronic kidney disease and risk of major cardiovascular disease and nonvascular mortality: prospective population based cohort study. BMJ 2010; 341:c4986.
9. Kronborg J, Jenssen T, Njolstad I, Toft I, Eriksen BO. Metabolic risk factors associated with serum creatinine in a nondiabetic population. Eur J Epidemiol 2007; 22:707-713. (Pubitemid 47476678)
10. Levey AS. Measurement of renal function in chronic renal disease. Kidney Int 1990; 38:167-184. (Pubitemid 20209447)
11. Mathisen UD, Melsom T, Ingebretsen OC, Jenssen T, Njølstad I, Solbu MD, et al. Estimated GFR associates with cardiovascular risk factors independently of measured GFR. J Am Soc Nephrol 2011; 22:927-937.
12. Bird NJ, Peters C, Michell AR, Peters AM. Comparison of GFR measurements assessed from single versus multiple samples. Am J Kidney Dis 2009; 54:278-288.
13. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139:137-147.
14. Kikuya M, Hansen TW, Thijs L, Bjorklund-Bodegard K, Kuznetsova T, Ohkubo T, et al. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation 2007; 115:2145-2152. (Pubitemid 46659066)
15. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007; 25:1751-1762. (Pubitemid 47356612)
16. Jacobsson L. A method for the calculation of renal clearance based on a single plasma sample. Clin Physiol 1983; 3:297-305. (Pubitemid 13014405)
17. Nilsson-Ehle P. Iohexol clearance for the determination of glomerular filtration rate: 15 years' experience in clinical practice. eJIFCC 2011; 13. http://www.ifcc.org/index.asp?cat=Publications&scat=eJIFCC-&rif= 6&dove=1.
18. Boijsen M, Jacobsson L, Tylen U. Glomerular filtration rate estimated from a single plasma sample after contrast-enhanced radiological examinations. Clin Physiol 1988; 8:309-316.
19. Sacamay TET, Bolton WK. Use of iohexol to quantify hemodialysis delivered and residual renal function. Kidney Int 1998; 54:986-991. (Pubitemid 28397420)
20. Du Bois D, Du Bois EF. The measurement of the surface area of man. Arch Intern Med 1915; 15:868-881.
21. Eriksen BO, Mathisen UD, Melsom T, Ingebretsen OC, Jenssen TG, Njolstad I, et al. Cystatin C is not a better estimator of GFR than plasma creatinine in the general population. Kidney Int 2010; 78:1305-1311.
22. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22:11-19. (Pubitemid 38293521)
23. Halbesma N, Jansen DF, Stolk RP, De Jong PE, Gansevoort RT. Changes in renal risk factors versus renal function outcome during follow-up in a population-based cohort study. Nephrol Dial Transplant 2010; 25:1846-1853.
24. Kronborg J, Solbu M, Njolstad I, Toft I, Eriksen BO, Jenssen T. Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study. Nephrol Dial Transplant 2008; 23:2818-2826.
25. Inoue T, Iseki K, Iseki C, Ohya Y, Kinjo K, Takishita S. Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort. Clin Exp Nephrol 2009; 13:487-493.
26. Kim JR, Kiefe CI, Liu K, Williams OD, Jacobs DR Jr, Oberman A. Heart rate and subsequent blood pressure in young adults: the CARDIA study. Hypertension 1999; 33:640-646. (Pubitemid 29091640)
27. Palatini P, Dorigatti F, Zaetta V, Mormino P, Mazzer A, Bortolazzi A, et al. Heart rate as a predictor of development of sustained hypertension in subjects screened for stage 1 hypertension: the HARVEST Study. J Hypertens 2006; 24:1873-1880. (Pubitemid 44253250)
28. Tjugen TB, Flaa A, Kjeldsen SE. High heart rate as predictor of essential hypertension: the hyperkinetic state, evidence of prediction of hypertension, and hemodynamic transition to full hypertension. Prog Cardiovasc Dis 2007; 52:20-25.
29. Palatini P, Benetos A, Grassi G, Julius S, Kjeldsen SE, Mancia G, et al. Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens 2006; 24:603-610.
30. Grassi G, Quarti-Trevano F, Dell'oro R, Mancia G. Essential hypertension and the sympathetic nervous system. Neurol Sci 2008; 29 (Suppl 1):S33-S36. (Pubitemid 351836959)
31. Kuchel O, Genest J. A neurogenic origin of mild high-renin essential hypertension? N Engl J Med 1977; 297:222.
32. DiBona GF. Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 2002; 11:197-200.
33. Schmieder RE, Messerli FH, Garavaglia G, Nunez B. Glomerular hyperfiltration indicates early target organ damage in essential hypertension. JAMA 1990; 264:2775-2780.
34. Griffin KA, Kramer H, Bidani AK. Adverse renal consequences of obesity. Am J Physiol Renal Physiol 2008; 294:F685-F696.
35. Jerums G, Premaratne E, Panagiotopoulos S, MacIsaac RJ. The clinical significance of hyperfiltration in diabetes. Diabetologia 2010; 53:2093-2104.
36. Schmieder RE, Veelken R, Schobel H, Dominiak P, Mann JF, Luft FC. Glomerular hyperfiltration during sympathetic nervous system activation in early essential hypertension. J Am Soc Nephrol 1997; 8:893-900. (Pubitemid 27427234)
37. Asmar R, Darne B, el Assaad M, Topouchian J. Assessment of outcomes other than systolic and diastolic blood pressure: pulse pressure, arterial stiffness and heart rate. Blood Press Monit 2001; 6:329-333. (Pubitemid 34194889)
38. Garcia-Garcia A, Gomez-Marcos MA, Recio-Rodriguez JI, Gonzalez-Elena LJ, Parra-Sanchez J, Fe Munoz-Moreno M, et al. Relationship between ambulatory arterial stiffness index and subclinical target organ damage in hypertensive patients. Hypertens Res 2011; 34:180-186.
39. Van Elderen SG, Westenberg JJ, Brandts A, van der Meer RW, Romijn JA, Smit JW, et al. Increased aortic stiffness measured by MRI in patients with type 1 diabetes mellitus and relationship to renal function. Am J Roentgenol 2011; 196:697-701.
40. Hermans MM, Henry R, Dekker JM, Kooman JP, Kostense PJ, Nijpels G, et al. Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn Study. J Am Soc Nephrol 2007; 18:1942-1952. (Pubitemid 46870332)
41. Fesler P, du Cailar G, Ribstein J, Mimran A. Glomerular hemodynamics and arterial function in normal individuals. J Hypertens 2010; 28:2462-2467.
42. Mimran A. Consequences of elevated pulse pressure on renal function. J Hypertens Suppl 2006; 24:S3-S7. (Pubitemid 44336812)
43. Upadhyay A, Hwang SJ, Mitchell GF, Vasan RS, Vita JA, Stantchev PI, et al. Arterial stiffness in mild-to-moderate CKD. J Am Soc Nephrol 2009; 20:2044-2053.
44. Khattar RS, Swales JD, Dore C, Senior R, Lahiri A. Effect of aging on the prognostic significance of ambulatory systolic, diastolic, and pulse pressure in essential hypertension. Circulation 2001; 104:783-789. (Pubitemid 32762676)